Patients sometimes have to stop using GLP-1 medications like Ozempic and Wegovy and risk regaining lost weight.

Injectable GLP-1 medications, like Ozempic, Mounjaro, Wegovy and Zepbound, have been the subject of a lot of excitement – ...

Semaglutide, better known as Ozempic and Wegovy, has added another string to its therapeutic bow. A recent international ...

Recent data reveals a sharp rise in the use of weight loss drugs among U.S. youth, with significant gender disparities and ...

New studies have linked popular diabetes and weight loss medications like Ozempic and Wegovy to an increased risk of stomach ...

Patients who received CT-388 had an average placebo-adjusted weight loss of 18.8%. CT-388 is well tolerated with only mild to ...

Interest in these drugs surged in 2021 when semaglutide was approved for weight management in adults under the brand name ...

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...